Ciproxifan
Ciproxifan is a potent and selective histamine H3 receptor antagonist and inverse agonist. It has been studied for its potential use in the treatment of various neurological conditions, including narcolepsy, attention deficit hyperactivity disorder (ADHD), and Alzheimer's disease.
Mechanism of Action
Ciproxifan works by blocking the histamine H3 receptor, which is primarily found in the central nervous system. The H3 receptor functions as an autoreceptor, regulating the release of histamine and other neurotransmitters such as dopamine, norepinephrine, and acetylcholine. By inhibiting this receptor, ciproxifan increases the release of these neurotransmitters, which can enhance cognitive function and alertness.
Pharmacology
Ciproxifan has been shown to cross the blood-brain barrier effectively, making it a viable candidate for central nervous system disorders. It exhibits high affinity and selectivity for the H3 receptor, with minimal activity at other histamine receptors, such as the histamine H1 receptor and histamine H2 receptor.
Potential Therapeutic Uses
Narcolepsy
Ciproxifan has been investigated for its potential to treat narcolepsy, a condition characterized by excessive daytime sleepiness and sudden loss of muscle tone (cataplexy). By increasing histamine release, ciproxifan may help to promote wakefulness and reduce sleep attacks.
Attention Deficit Hyperactivity Disorder (ADHD)
Research suggests that ciproxifan could be beneficial in treating ADHD by enhancing the release of neurotransmitters involved in attention and focus, such as dopamine and norepinephrine.
Alzheimer's Disease
Ciproxifan has also been studied for its potential to improve cognitive function in patients with Alzheimer's disease. By increasing the release of acetylcholine, a neurotransmitter that is typically deficient in Alzheimer's patients, ciproxifan may help to alleviate some of the cognitive deficits associated with the disease.
Side Effects
The side effects of ciproxifan are not well-documented, as it is still primarily in the research phase. However, potential side effects could include those commonly associated with increased histamine release, such as insomnia, anxiety, and gastrointestinal disturbances.
Research and Development
Ciproxifan is still under investigation, and more research is needed to fully understand its efficacy and safety profile. Clinical trials are ongoing to determine its potential therapeutic benefits and any long-term side effects.
See Also
- Histamine
- Histamine receptor
- Narcolepsy
- Attention deficit hyperactivity disorder
- Alzheimer's disease
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD